Impact of vaginal douching products on vaginal Lactobacillus, Escherichia coli and epithelial immune responses.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 11 2021
Historique:
received: 30 06 2021
accepted: 09 11 2021
entrez: 30 11 2021
pubmed: 1 12 2021
medline: 27 1 2022
Statut: epublish

Résumé

We compared the effect of commercial vaginal douching products on Lactobacillus crispatus, L. jensenii, L. gasseri, L. iners, E. coli, and immortalized vaginal epithelial cells (VK2). All studied douching products (vinegar, iodine and baking soda based) induced epithelial cell death, and all inhibited growth of E. coli. Co-culture of vaginal epithelial cells with any of the lactobacilli immediately following exposure to douching products resulted in a trend to less human cell death. However, co-culture of epithelial cells with L. iners was associated with higher production of IL6 and IL8, and lower IL1RA regardless of presence or type of douching solution. Co-culture with L. crispatus or L. jensenii decreased IL6 production in the absence of douches, but increased IL6 production after exposure to vinegar. Douching products may be associated with epithelial disruption and inflammation, and may reduce the anti-inflammatory effects of beneficial lactobacilli.

Identifiants

pubmed: 34845288
doi: 10.1038/s41598-021-02426-5
pii: 10.1038/s41598-021-02426-5
pmc: PMC8629978
doi:

Substances chimiques

CXCL8 protein, human 0
Cytokines 0
IL6 protein, human 0
Interleukin-6 0
Interleukin-8 0
Sodium Bicarbonate 8MDF5V39QO
Iodine 9679TC07X4
Acetic Acid Q40Q9N063P

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23069

Informations de copyright

© 2021. The Author(s).

Références

Am J Obstet Gynecol. 2008 Jun;198(6):628.e1-7
pubmed: 18295180
Sex Transm Dis. 2021 Jan;48(1):63-70
pubmed: 32842049
J Infect Dis. 2002 May 1;185(9):1307-13
pubmed: 12001048
Sex Transm Infect. 2020 Sep;96(6):439-444
pubmed: 31810995
Eur J Clin Microbiol Infect Dis. 1992 Dec;11(12):1166-9
pubmed: 1291315
Clin Infect Dis. 2011 May;52(10):1212-7
pubmed: 21498386
BMC Microbiol. 2019 Jul 25;19(1):168
pubmed: 31345159
J Infect Dis. 2016 Nov 1;214(9):1370-1375
pubmed: 27553042
PLoS One. 2020 Nov 25;15(11):e0242711
pubmed: 33237976
Am J Obstet Gynecol. 2002 May;186(5):916-7
pubmed: 12015512
J Womens Health (Larchmt). 2020 Jan;29(1):65-73
pubmed: 31532304
J Infect Dis. 2000 Oct;182(4):1177-82
pubmed: 10979915
Sex Transm Infect. 2013 May;89(3):217-22
pubmed: 23002190
Sex Transm Dis. 2013 Sep;40(9):751-5
pubmed: 23949590
Sex Transm Infect. 2019 Sep;95(6):455-461
pubmed: 30696752
AIDS Res Hum Retroviruses. 2017 Apr;33(4):309-317
pubmed: 27897054
Obstet Gynecol. 2002 Oct;100(4):765
pubmed: 12383547
Immunity. 2017 Jan 17;46(1):29-37
pubmed: 28087240
PLoS One. 2016 Mar 11;11(3):e0151378
pubmed: 26967165
J Obstet Gynaecol. 2007 Apr;27(3):252-4
pubmed: 17464804
Infect Dis Clin North Am. 2014 Mar;28(1):1-13
pubmed: 24484571
Sex Transm Dis. 2020 Aug;47(8):562-569
pubmed: 32520883
J Infect Dis. 2005 Mar 15;191(6):924-9
pubmed: 15717268
PLoS One. 2012;7(11):e48328
pubmed: 23144863
Clin Infect Dis. 1999 Jul;29(1):113-9
pubmed: 10433573
J Infect Dis. 2016 Aug 15;214 Suppl 1:S6-S13
pubmed: 27449872
PLoS One. 2015 Dec 16;10(12):e0141905
pubmed: 26675816
Vital Health Stat 13. 2011 Apr;(169):1-38
pubmed: 21614897
Immunity. 2015 May 19;42(5):965-76
pubmed: 25992865
PLoS One. 2019 Jan 24;14(1):e0210825
pubmed: 30677048
J Infect Dis. 1998 Aug;178(2):446-50
pubmed: 9697725
Sci Rep. 2020 May 6;10(1):7625
pubmed: 32376907
J Pediatr Adolesc Gynecol. 2012 Feb;25(1):48-53
pubmed: 22051790
J Infect Dis. 2019 Nov 6;220(12):2009-2018
pubmed: 31539059
Microb Ecol Health Dis. 2013 Feb 25;24:
pubmed: 24009546
Microb Pathog. 2020 Nov;148:104544
pubmed: 33010368
Infect Dis Obstet Gynecol. 2000;8(2):99-104
pubmed: 10805365
AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):992-1004
pubmed: 27611224
AIDS. 2006 Jan 9;20(2):269-73
pubmed: 16511421
Obstet Gynecol. 1992 Sep;80(3 Pt 1):333-8
pubmed: 1495688
Sex Transm Dis. 2006 Oct;33(10):610-3
pubmed: 16614585

Auteurs

Helai Hesham (H)

Division of Female Pelvic Medicine and Reconstructive Surgery, Massachusetts General Hospital, Boston, MA, USA.
Division of Female Pelvic Medicine and Reconstructive Surgery, Columbia University Medical Center, New York, USA.

Alissa J Mitchell (AJ)

Vincent Center for Reproductive Biology, Massachusetts General Hospital, 55 Fruit St., Boston, MA, 02114, USA.

Agnes Bergerat (A)

Vincent Center for Reproductive Biology, Massachusetts General Hospital, 55 Fruit St., Boston, MA, 02114, USA.

Kristin Hung (K)

Division of Female Pelvic Medicine and Reconstructive Surgery, Massachusetts General Hospital, Boston, MA, USA.

Caroline M Mitchell (CM)

Vincent Center for Reproductive Biology, Massachusetts General Hospital, 55 Fruit St., Boston, MA, 02114, USA. caroline.mitchell@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH